Alan B. Lancz & Associates, Inc. Medtronic PLC Transaction History
Alan B. Lancz & Associates, Inc.
- $97.3 Million
- Q4 2024
A detailed history of Alan B. Lancz & Associates, Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Alan B. Lancz & Associates, Inc. holds 9,958 shares of MDT stock, worth $888,751. This represents 0.82% of its overall portfolio holdings.
Number of Shares
9,958
Previous 10,658
6.57%
Holding current value
$888,751
Previous $959,000
17.1%
% of portfolio
0.82%
Previous 0.89%
Shares
9 transactions
Others Institutions Holding MDT
# of Institutions
2,277Shares Held
1.02BCall Options Held
8.05MPut Options Held
7.19M-
Vanguard Group Inc Valley Forge, PA123MShares$11 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY112MShares$9.99 Billion0.2% of portfolio
-
State Street Corp Boston, MA60.7MShares$5.42 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA32.6MShares$2.91 Billion0.63% of portfolio
-
Jpmorgan Chase & CO New York, NY30.7MShares$2.74 Billion0.23% of portfolio
About Medtronic plc
- Ticker MDT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,329,149,952
- Market Cap $119B
- Description
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...